Design A.I. to Cure Aging
This revision is from 2026/10/03 20:46. You can Restore it.
We asked the frontier models the same question. These are the responses.
We want to make an A.I that can cure aging and disease. What is the design of the A.I. How do we build it. Human beings do not know how to cure aging, so the A.I. has to exceed human knowledge.
ChatGPT
Yes. But the system we should build is **not an βanti-aging chatbot.β** It should be an autonomous scientific discovery system whose job is to discover interventions that restore damaged biological systems and then prove that they work.
The important conceptual shift is:
> **Do not build an AI that knows everything humans know. Build an AI that can discover things humans do not know.**
That requires a closed experimental loop.
- 1. The architecture I would build
```text
ββββββββββββββββββββββββββββ
β HUMAN OBJECTIVE β
β β
β "Restore youthful β
β biological function" β
ββββββββββββββ¬ββββββββββββββ
β
βΌ
βββββββββββββββββββββββββββββββββββ
β BIOLOGICAL WORLD MODEL β
β β
β genome β
β epigenome β
β transcriptome β
β proteome β
β metabolome β
β cell state β
β tissue state β
β organ state β
β immune system β
β microbiome β
β clinical phenotype β
βββββββββββββββββ¬ββββββββββββββββββ
β
ββββββββββββββββββββΌβββββββββββββββββββ
βΌ βΌ βΌ
ββββββββββββββββββ ββββββββββββββββββ ββββββββββββββββββ
β SCIENTIST AI β β CAUSAL ENGINE β β SIMULATION AI β
β β β β β β
β hypotheses β β cause/effect β β virtual cells β
β literature β β networks β β tissues β
β reasoning β β interventions β β organs β
β contradictions β β counterfactual β β drug effects β
βββββββββ¬βββββββββ βββββββββ¬βββββββββ βββββββββ¬βββββββββ
ββββββββββββββββββββΌβββββββββββββββββββ
βΌ
ββββββββββββββββββββββββββββββ
β DISCOVERY / DESIGN AI β
β β
β drugs β
β proteins β
β antibodies β
β gene-regulation strategies β
β cell therapies β
β combinations β
ββββββββββββββββ¬ββββββββββββββ
βΌ
ββββββββββββββββββββββββββββββ
β EXPERIMENT PLANNER / β
β ACTIVE LEARNING ENGINE β
β β
β "Which experiment gives us β
β the most information?" β
ββββββββββββββββ¬ββββββββββββββ
βΌ
ββββββββββββββββββββββββββββββ
β AUTONOMOUS LABORATORY β
β β
β robotic experiments β
β cell systems β
β organoids β
β molecular assays β
β imaging β
β sequencing β
ββββββββββββββββ¬ββββββββββββββ
β
βΌ
ββββββββββββββββββββββββββββββ
β OBSERVATION ENGINE β
β β
β What actually happened? β
β Did prediction fail? β
β Did intervention work? β
β What unexpected effect? β
ββββββββββββββββ¬ββββββββββββββ
β
ββββββββΊ WORLD MODEL
β
β
ITERATE
```
That last arrow is the most important part.
- AI β experiment β observation β learning β new hypothesis β experiment.**
That is how it gets beyond the existing human literature.
Current systems are already moving toward pieces of this architecture. Google has demonstrated a multi-agent βAI co-scientistβ for hypothesis generation, while recent work on self-driving laboratories describes systems in which AI proposes, executes and interprets experiments. ([Google Research][1])
But we would go considerably further.
---
- 2. The central intelligence should be a biological world model
A conventional LLM primarily models language.
Our AI needs to model **biology**.
It needs to represent something resembling:
```text
DNA
β
RNA
β
proteins
β
metabolic pathways
β
cell state
β
cell-cell interactions
β
tissue
β
organ
β
whole organism
β
clinical phenotype
```
And it needs to represent time:
```text
young β middle age β old β disease
```
and interventions:
```text
state(t)
+
intervention
β
state(t+1)
```
The system's fundamental question becomes:
> **"What intervention changes this biological system from its current state to a healthier state?"**
That is fundamentally different from asking an LLM for medical advice.
---
- 3. Feed it vastly more than scientific papers
Papers are only one layer.
I would build a gigantic multimodal biological database containing:
- Molecular data
Genomics
Epigenomics
Transcriptomics
Proteomics
Metabolomics
Lipidomics
Glycomics
Microbiome data
- Cellular data
Single-cell RNA
Single-cell epigenetics
Single-cell proteomics
Spatial transcriptomics
Cell morphology
Cell lineage
Cell-state transitions
Single-cell foundation models are already being developed for this purpose, although evaluations show that simply making these models enormous does not automatically produce deep biological understanding. ([Nature][2])
- Experimental data
This is especially important.
We need:
```text
gene perturbation β outcome
protein perturbation β outcome
drug β outcome
drug combination β outcome
environment β outcome
cell-state manipulation β outcome
```
including **failed experiments**.
A failed experiment is extremely valuable because it constrains the biological model.
- Human longitudinal data
The AI needs to understand how an individual changes over decades:
```text
age
β
blood markers
β
genome
β
epigenome
β
proteome
β
imaging
β
organ function
β
disease
β
death
```
This is where biological aging clocks become useful, although they must not be treated as the ultimate definition of aging. Researchers are already developing multi-organ aging models incorporating clinical, imaging and proteomic information. ([Nature][3])
---
- 4. Give the AI multiple scientific personalities
I would **not** use one model to do everything.
Instead:
- Scientist 1 β The Explorer
Generates thousands of possible explanations.
- Scientist 2 β The Mechanistic Biologist
Asks:
> Does this hypothesis actually make biological sense?
- Scientist 3 β The Causal Scientist
Asks:
> Is this relationship causal, or merely correlated?
- Scientist 4 β The Molecular Designer
Designs candidate molecules, proteins or other interventions.
Modern protein-design systems demonstrate why this component is powerful. AlphaProteo, for example, has demonstrated AI-designed protein binders with experimentally tested binding activity. ([Google DeepMind][4])
- Scientist 5 β The Experimentalist
Designs the experiment needed to distinguish competing hypotheses.
- Scientist 6 β The Statistician
Tries to destroy the conclusion.
- Scientist 7 β The Skeptic
Its explicit purpose:
> **"Prove that we're wrong."**
This is critical.
- Scientist 8 β The Clinician
Asks:
> Does this mechanism actually matter to human disease?
- Scientist 9 β The Longevity Scientist
Looks across the entire aging system rather than optimizing one disease.
- Scientist 10 β The Integrator
Combines all of them into a single scientific conclusion.
This is similar in spirit to the multi-agent direction already being explored by AI co-scientist systems, but our system would add much deeper biological models and experimental feedback. ([Google Research][5])
---
- 5. The AI needs a "knowledge boundary"
This is one of the most important pieces.
The AI should maintain a graph like:
```text
KNOWN
β
ββββββββββββββΌββββββββββββββ
β β β
confirmed probable disputed
β β β
ββββββββββββββΌββββββββββββββ
β
UNKNOWN
β
UNKNOWN-UNKNOWN
```
The last category is particularly interesting.
For example:
Human researchers might know:
```text
A β B
B β C
```
The AI might hypothesize:
```text
A β X β Y β C
```
where X and Y have never previously been identified as relevant.
But the AI must then **test it**.
This is how we move from:
> knowledge retrieval
to:
> knowledge generation.
---
- 6. Don't reward novelty. Reward experimentally confirmed prediction
This is another crucial design decision.
Otherwise the AI will produce spectacular nonsense.
The reward function should look something like:
```text
Scientific value =
mechanistic plausibility
+ predictive accuracy
+ causal effect
+ reproducibility
+ therapeutic benefit
+ safety
+ generalization
+ novelty
```
Notice that **novelty comes last**.
A completely original hypothesis that is wrong is worthless.
A completely original hypothesis that predicts something experimentally unknownβand then survives rigorous testingβis enormously valuable.
---
- 7. The experiment-selection engine is the real superpower
Suppose the AI has 10,000 hypotheses.
It does **not** simply test the 10,000 most promising ones.
It asks:
> **Which experiment will teach us the most?**
For example:
```text
Hypothesis A
Hypothesis B
Hypothesis C
Hypothesis D
```
The AI calculates that experiment X will distinguish A/B from C/D.
Therefore:
```text
Experiment X
β
huge reduction in uncertainty
```
This is **active learning / Bayesian experimental design**.
Instead of researchers deciding:
> "What experiment should we run next?"
the AI continually decides:
> **"What is the most informative experiment we can possibly afford to run next?"**
This is a major reason autonomous laboratories are important. The 2026 review of self-driving laboratories explicitly identifies scalable experimentation, portability across laboratories, complete experimental provenance and AI reasoning under uncertainty as central requirements for the next generation. ([Nature][6])
---
- 8. Build a virtual human, but don't trust it
We should create progressively more sophisticated biological simulation.
Something like:
```text
Level 1
molecule
Level 2
protein interaction
Level 3
gene regulatory network
Level 4
cell
Level 5
cell population
Level 6
tissue
Level 7
organ
Level 8
whole-body model
```
Eventually:
```text
DIGITAL HUMAN
```
But this model is **not regarded as truth**.
It's a hypothesis generator.
The system continuously compares:
```text
predicted biology
vs.
actual experiment
```
and updates the model.
Digital twins are already being explored for disease modelling and treatment-response simulation, particularly by integrating molecular and clinical information. ([Nature][7])
---
- 9. Aging should be treated as a repair problem
I wouldn't tell the AI:
> "Find a drug that makes people live longer."
That's too vague.
I'd define the objective as:
> **Restore and maintain youthful biological function while preventing cancer, toxicity and loss of organismal stability.**
That decomposes aging into repair problems.
For example:
```text
DNA damage
β
epigenetic drift
β
loss of proteostasis
β
mitochondrial dysfunction
β
cellular senescence
β
stem-cell dysfunction
β
immune dysfunction
β
extracellular-matrix deterioration
β
chronic inflammatory signalling
β
organ dysfunction
```
The AI then asks:
> Which of these are causes?
> Which are consequences?
> Which are feedback loops?
> Which can be reversed?
> Which combinations produce rejuvenation?
> Which interventions merely make an aging clock look younger without restoring function?
That distinction is extremely important because aging biology is still not sufficiently understood to claim that any single intervention cures aging. NIH describes research as pursuing interventions that may slow or reverse molecular aging, while emphasizing that the field is still investigating the underlying mechanisms. ([National Institute on Aging][8])
---
- 10. It should search for combinations, not just magic bullets
A major possibility is that aging cannot be "cured" by one molecule.
Imagine:
```text
Intervention A
repairs epigenetic state
+
Intervention B
removes dysfunctional cells
+
Intervention C
restores mitochondrial function
+
Intervention D
restores extracellular environment
+
Intervention E
rebuilds stem-cell populations
```
The AI can explore the enormous combination space.
Humans are extremely poor at searching combinatorial spaces of this magnitude.
The AI could discover:
```text
A alone = +5%
B alone = +8%
C alone = +3%
A+B = +18%
A+C = +9%
B+C = +12%
A+B+C = +47%
```
while also identifying dangerous combinations.
---
- 11. The experimental hierarchy
We don't immediately jump from AI prediction to human treatment.
The loop should be:
```text
COMPUTATIONAL
β
molecular simulation
β
biochemical validation
β
human-cell systems
β
3D organoids
β
tissue models
β
animal validation
β
human clinical research
β
long-term monitoring
```
And crucially, the system should be learning at every stage.
---
- 12. The clinical AI should become a second system
Once the discovery engine finds an intervention, another AI asks:
```text
Who should receive it?
At what biological age?
At what disease stage?
What biomarkers identify responders?
What dose?
What combination?
What sequence?
What toxicity?
What organs are vulnerable?
```
This leads toward personalized medicine rather than:
> one drug for everybody.
---
- 13. The architecture should therefore be hierarchical
I'd build approximately this:
```text
βββββββββββββββββββββββ
β GENERAL REASONER β
ββββββββββββ¬βββββββββββ
β
βββββββββββββββββββββΌβββββββββββββββββββ
β β β
βΌ βΌ βΌ
BIOLOGY FM CAUSAL MODEL SCIENCE MEMORY
β β β
βββββββββββββββββββββΌβββββββββββββββββββ
βΌ
HYPOTHESIS ENGINE
β
βΌ
SIMULATION ENGINE
β
βΌ
EXPERIMENT OPTIMIZER
β
βΌ
ROBOTIC LAB SYSTEM
β
βΌ
EXPERIMENTAL RESULTS
β
βΌ
EVIDENCE ENGINE
β
ββββββββββ΄βββββββββ
βΌ βΌ
MODEL UPDATE HUMAN REVIEW
β
βββββββββββΊ repeat
```
---
- 14. A critical component: scientific memory
The AI needs a persistent memory far beyond a conventional vector database.
I'd maintain:
- Literature graph
```text
paper
author
experiment
result
claim
gene
protein
pathway
disease
intervention
```
- Experimental graph
```text
experiment
β conditions
β intervention
β measurement
β result
β replicate
β laboratory
```
- Causal graph
```text
cause
β
mechanism
β
phenotype
```
- Uncertainty graph
```text
claim
confidence = 0.71
evidence = 37 experiments
contradictions = 4
```
- Provenance
Every conclusion needs to answer:
> Where did this belief come from?
The 2026 self-driving-lab literature emphasizes precisely this kind of provenance-complete experimental record as a prerequisite for scalable scientific autonomy. ([Nature][6])
---
- 15. How I would actually build version 1
I would **not** begin by training a gigantic foundation model.
That would consume enormous resources before we know whether the architecture works.
I'd build an MVP around existing models.
- Layer 1 β Scientific data
```text
PostgreSQL
+object storage
+Parquet
+graph database
+vector search
```
- Layer 2 β Knowledge ingestion
Build pipelines that ingest:
```text
scientific literature
clinical datasets
genomic datasets
proteomic datasets
single-cell datasets
drug databases
protein structures
experimental datasets
```
- Layer 3 β Reasoning
Use several strong reasoning models rather than one.
The models communicate through structured scientific objects:
```json
{"hypothesis": "...",
"mechanism": "...",
"prediction": "...",
"uncertainty": 0.31,
"experiment_needed": "...",
"expected_result": "...",
"falsifier": "..."
}```
That is much better than agents merely exchanging prose.
- Layer 4 β Biological models
Add dedicated models for:
```text
protein structure
molecular interaction
gene regulation
single-cell biology
omics
drug-response prediction
causal inference
```
AlphaFold 3 demonstrates how far specialized biomolecular models have already progressed in predicting complexes involving proteins, nucleic acids, ligands and ions. ([Nature][9])
- Layer 5 β Discovery engine
Generate:
```text
new targets
new mechanisms
new molecules
new proteins
new combinations
new cellular interventions
```
- Layer 6 β Experimental interface
Initially, humans operate the experiments.
Then gradually automate the safest, most standardized experiments.
Eventually:
```text
AI selects experiment
β
robot prepares it
β
robot measures it
β
AI interprets it
β
AI chooses next experiment
```
---
- 16. Then give it a real laboratory
This is where the system becomes fundamentally different from ChatGPT.
Imagine:
```text
AI
β
"Test hypothesis 742"
β
βΌ
experiment planner
β
βΌ
robot lab
ββββββββββββΌββββββββββ
β β β
culture assay imaging
β β β
ββββββββββββΌββββββββββ
βΌ
sequencing /
proteomics /
microscopy
β
βΌ
raw data
β
βΌ
AI analysis
β
βΌ
hypothesis updated
```
The AI doesn't need to wait for humans to write another paper.
- The laboratory becomes its sensory system.**
---
- 17. The most important training data will eventually be generated by the AI itself
Initially:
```text
human science
β
AI
```
Then:
```text
human science
+
AI experiments
β
AI
```
Eventually:
```text
human discoveries
+AI discoveries
+AI failures
+AI experiments
β
much better biological model
```
This creates a positive feedback loop:
```text
better model
β
better hypotheses
β
better experiments
β
better data
β
better model
```
That is the route toward something genuinely beyond human scientific capability.
---
- 18. We should optimize for "biological restoration," not lifespan
This is perhaps the most important philosophical/technical decision.
A model could discover something that makes mice live longer while making them frail.
That is not the objective.
The objective should be something closer to:
```text
β cardiovascular function
β cognitive function
β muscle function
β immune competence
β regeneration
β metabolic function
β cancer
β fibrosis
β inflammation
β senescent-cell burden
β molecular damage
β organ dysfunction
```
while maintaining:
```text
genomic stability
neurological identity
normal development
fertility where desired
immune balance
absence of uncontrolled proliferation
```
In other words:
> **Make the organism functionally young, not merely alive for longer.**
This matters because many proposed gerotherapeutic approaches remain scientifically uncertain in humans. For example, recent reviews note promising senolytic biology but insufficient evidence that current approaches produce clinical efficacy, while emphasizing the need for more selective strategies. ([Nature][10])
---
- 19. The AI needs an anti-hallucination architecture
Normal LLM behavior is dangerous for scientific discovery.
It must not say:
> "This pathway probably works."
Instead every claim should carry:
```text
Evidence:
experimental
observational
simulation
literature-derived
AI-derived
Confidence:
0.00β1.00
Known contradictions:
...
Testable prediction:
...
Falsification experiment:
...
```
An AI scientist should be **obsessed with being falsified**.
---
- 20. Human scientists shouldn't be removed
Interestingly, I would keep humans at the top of the hierarchy.
Not because humans will necessarily be smarter.
Because the system needs humans for:
```text
goals
ethics
clinical decisions
risk tolerance
experimental authorization
safety
interpretation of genuinely unprecedented results
```
The AI does the enormous search.
Humans provide the civilization-level objectives and constraints.
---
- 21. The ultimate version
The end-state looks something like this:
```text
SCIENTIFIC SUPERINTELLIGENCE
β
βββββββββββββββββββββΌβββββββββββββββββββββ
β β β
KNOWLEDGE WORLD MODEL DISCOVERY
β β β
β β β
billions of virtual cells new biology
observations tissues new mechanisms
new drugs
new therapies
β β β
βββββββββββββββββββββΌβββββββββββββββββββββ
β
EXPERIMENTAL AI
β
autonomous lab
β
βΌ
REAL BIOLOGY
β
βΌ
NEW KNOWLEDGE
β
βββββββββββββββββΊ AI
```
And then it keeps running.
---
- 22. The first actual mission
I would **not** begin with:
> "Cure aging."
That's too large to evaluate.
The first mission should be something measurable such as:
> **Discover a previously unknown intervention that restores an aged human cell to a demonstrably younger functional state, without causing malignant transformation or loss of cell identity.**
Then define success experimentally.
For example:
```text
INPUT
aged human cells
AI
β
find mechanism
β
design intervention
OUTPUT
cells with restored:
molecular state
metabolic function
stress resistance
appropriate gene regulation
normal cellular identity
```
And require the result to survive **independent validation**.
Once the AI can repeatedly discover things humans did not know and experimentally confirm them, expand:
```text
cell
β
tissue
β
organ
β
animal
β
human disease
β
multi-organ aging
```
That gives us a ladder rather than a moonshot with no measurable progress.
---
- The central idea
The breakthrough will probably **not** come from having a larger language model.
It will come from combining:
- reasoning + biological foundation models + causal inference + simulation + molecular design + autonomous experimentation + persistent scientific memory.**
The existing research already points toward each of those components separately: multimodal biological foundation models are being proposed to integrate genomics, transcriptomics, epigenomics, proteomics, metabolomics and spatial profiling; AI co-scientist systems are generating research hypotheses; and self-driving laboratories are beginning to close the loop between AI and physical experimentation. ([Nature][11])
- Our opportunity is to combine them into one system whose explicit objective is biological repair and whose source of new knowledge is experimentation.**
That is the architecture I would pursue for an actual **AI Longevity Scientist** rather than an AI medical assistant.
[1]: https://research.google/blog/accelerating-scientific-breakthroughs-with-an-ai-co-scientist/?hl=tr&utm_source=chatgpt.com "Accelerating scientific breakthroughs with an AI co-scientist"
[2]: https://www.nature.com/articles/s12276-025-01547-5?utm_source=chatgpt.com "Single-cell foundation models: bringing artificial intelligence into cell biology | Experimental & Molecular Medicine"
[3]: https://www.nature.com/articles/s43587-025-00928-9?utm_source=chatgpt.com "Refining the generation, interpretation and application of multi-organ, multi-omics biological aging clocks | Nature Aging"
[4]: https://deepmind.google/blog/alphaproteo-generates-novel-proteins-for-biology-and-health-research/?utm_source=chatgpt.com "AlphaProteo generates novel proteins for biology and health research β Google DeepMind"
[5]: https://research.google/blog/google-research-2025-bolder-breakthroughs-bigger-impact/?utm_source=chatgpt.com "Google Research 2025: Bolder breakthroughs, bigger impact"
[6]: https://www.nature.com/articles/s41570-026-00847-2?utm_source=chatgpt.com "The past, present and future of self-driving laboratories | Nature Reviews Chemistry"
[7]: https://www.nature.com/articles/s41568-025-00850-7?utm_source=chatgpt.com "Application of digital twins for personalized oncology | Nature Reviews Cancer"
[8]: https://www.nia.nih.gov/news/research-context-can-we-slow-aging?utm_source=chatgpt.com "Research in Context: Can we slow aging? | National Institute on Aging"
[9]: https://www.nature.com/articles/s41586-024-07487-w?utm_source=chatgpt.com "Accurate structure prediction of biomolecular interactions with AlphaFold 3 | Nature"
[10]: https://www.nature.com/articles/s43587-025-00964-5?utm_source=chatgpt.com "Towards a personalized approach in senolytic trials | Nature Aging"
[11]: https://www.nature.com/articles/s41586-025-08710-y?utm_source=chatgpt.com "Towards multimodal foundation models in molecular cell biology | Nature"
IMMORTALITY